M&T Bank’s Praxis Precision Medicines PRAX Stock Holding History

M&T Bank’s Portfolio PRAX Stock Details PRAX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$323K	Buy	966 +31	+3%	+$9.81K	﹤0.01%	1428
2026 Q1	$301K	Buy	935 +50	+6%	+$15.5K	﹤0.01%	1380
2025 Q4	$261K	Buy	+885	New	+$165K	﹤0.01%	1464

Other funds holding PRAX

Jupiter Topco New York $245B AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

OAG

Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

M&T Bank's PRAX Position: Q2 2026 in Review

M&T Bank increased its Praxis Precision Medicines (PRAX) stake by 3.3% in Q2 2026, buying an estimated $9.81K and bringing the position to 966 shares worth $323K. The position accounts for ﹤0.01% of the portfolio, ranked #1428.

M&T Bank first reported a position in PRAX in Q4 2025 and has held it in 3 quarters since. 309 funds tracked by Wall St. Rank hold PRAX as of Q2 2026.

M&T Bank held 966 shares of Praxis Precision Medicines worth $323K as of Q2 2026.
M&T Bank bought 31 Praxis Precision Medicines shares in Q2 2026, an estimated $9.81K.
Praxis Precision Medicines made up ﹤0.01% of M&T Bank's portfolio in Q2 2026, its #1428 holding.
M&T Bank first reported a position in Praxis Precision Medicines in Q4 2025 and has held it in 3 quarters since.
309 funds tracked by Wall St. Rank held Praxis Precision Medicines as of Q2 2026.

Based on M&T Bank's 13F filing for Q2 2026, filed 4 Aug 2026.